Download Mental Health Bulletin, July 2008

Gynaecologic Oncology
July 2014
This bulletin covers aspects of gynaecological cancers and should be of interest to multidisciplinary
teams working in this area.
Sections can include:
 Combined Modality Therapies
 Drug Therapy
 Pathology, Staging, Polymorphisms & Biomarkers
 Prognosis, Survival & Risk Factors
 Radiotherapy & Imaging
 Supportive Care & Symptom Management
 Surgery
Many of the following articles are available online via the NHS Scotland Knowledge Network.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk/
If the article you require is not available via the NHS Scotland Knowledge Network and you
would like to request a print copy, please submit your request online at
www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base, and is
not intended to be comprehensive. Professional judgment should be exercised when appraising
the material. The Library takes no responsibility for the wording, content and accuracy of the
information supplied, which has been extracted in good faith from reputable sources. NHSGGC is
not responsible for the content of external internet sites.
Compiled by:
Kirsty Coltart
Subject Librarian
Beatson West of Scotland Cancer Centre
0141 301 7285, [email protected]
1
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
General
Collinson, F., Qian, W., Fossati, R., et al. (2014). Optimal treatment of early-stage
ovarian cancer. Annals of Oncology 25,6:1165-1171.
Deppe, G., Mert, I. and Winer, I.S. (2014). Management of squamous cell vulvar
cancer: a review. Journal of Obstetrics & Gynaecology Research 40,5:1217-1225.
Grimm, D., Woelber, L., Trillsch, F., et al. (2014). Clinical management of epithelial
ovarian cancer during pregnancy. European journal of cancer 50,5:963-971.
Guitarte, C., Alagkiozidis, I., Mize, B., et al. (2014). Glassy cell carcinoma of the cervix:
a systematic review and meta-analysis. Gynecologic oncology 133,2:186-191.
Combined Modality Therapies
Erpolat, O.P., Alco, G., Caglar, H.B., et al. (2014). Comparison of hematologic toxicity
between 3DCRT and IMRT planning in cervical cancer patients after concurrent
chemoradiotherapy: a national multi-center study. European journal of gynaecological
oncology 35,1:62-66.
Galaal, K., Al Moundhri, M., Bryant, A., et al. (2014). Adjuvant chemotherapy for
advanced endometrial cancer. Cochrane Database of Systematic Reviews 5,010681.
Nogueira-Rodrigues, A., Moralez, G., Grazziotin, R., et al. (2014). Phase 2 trial of erlotinib
combined with cisplatin and radiotherapy in patients with locally advanced cervical
cancer. Cancer 120,8:1187-1193.
Noh, J.M., Park, W., Kim, Y.S., et al. (2014). Comparison of clinical outcomes of
adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients
receiving surgical resection followed by radiotherapy: a multicenter retrospective
study (KROG 13-10). Gynecologic oncology 132,3:618-623.
Sugiyama, T., Fujiwara, K., Ohashi, Y., et al. (2014). Phase III placebo-controlled
double-blind randomized trial of radiotherapy for stage IIB-IVA cervical cancer
with or without immunomodulator Z-100: a JGOG study. Annals of Oncology
25,5:1011-1017.
Vizza, E., Corrado, G., Zanagnolo, V., et al. (2014). Neoadjuvant chemotherapy followed
by robotic radical hysterectomy in locally advanced cervical cancer: a multiinstitution study. Gynecologic oncology 133,2:180-185.
Drug & Targeted Therapy
Aghajanian, C., Goff, B., Nycum, L.R., et al. (2014). Independent radiologic review:
bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian
cancer. Gynecologic oncology 133,1:105-110.
Burger, R.A., Brady, M.F., Bookman, M.A., et al. (2014). Risk factors for GI adverse
events in a phase III randomized trial of bevacizumab in first-line therapy of
advanced ovarian cancer: A Gynecologic Oncology Group Study. Journal of Clinical
Oncology 32,12:1210-1217.
2
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Glasspool, R.M., Brown, R., Gore, M.E., et al. (2014). A randomised, phase II trial of the
DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination
with carboplatin vs carboplatin alone in patients with recurrent, partially platinumsensitive ovarian cancer. British journal of cancer 110,8:1923-1929.
Husseinzadeh, N. and Husseinzadeh, H.D. (2014). mTOR inhibitors and their clinical
application in cervical, endometrial and ovarian cancers: a critical review.
Gynecologic oncology 133,2:375-381.
Kristensen, G.S., Schledermann, D., Mogensen, O., et al. (2014). The value of random
biopsies, omentectomy, and hysterectomy in operations for borderline ovarian
tumors. International Journal of Gynecological Cancer 24,5:874-879.
Lee, P.S. and Secord, A.A. (2014). Targeting molecular pathways in endometrial
cancer: a focus on the FGFR pathway. Cancer treatment reviews 40,4:507-512.
Liu, J.F., Konstantinopoulos, P.A. and Matulonis, U.A. (2014). PARP inhibitors in ovarian
cancer: current status and future promise. Gynecologic oncology 133,2:362-369.
Lorusso, D., Petrelli, F., Coinu, A., et al. (2014). A systematic review comparing
cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or
metastatic cervical cancer. Gynecologic oncology 133,1:117-123.
Pignata S. Scambia G. Katsaros D. Gallo C. Pujade-Lauraine E. De Placido S. Bologna A.
Weber B. Raspagliesi F. Panici PB. Cormio G. Sorio R. Cavazzini MG. Ferrandina G. Breda E.
Murgia V. Sacco C. Cinieri S. Salutari V. Ricci C. Pisano C. Greggi S. Lauria R. Lorusso D.
Marchetti C. Selvaggi L. Signoriello S. Piccirillo MC. Di Maio M. Perrone F. Multicentre Italian
Trials in Ovarian cancer (MITO-7). Groupe d'Investigateurs Nationaux pour l'Etude des
Cancers Ovariens et du sein (GINECO). Mario Negri Gynecologic Oncology (MaNGO).
European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10). Gynecologic
Cancer InterGroup (GCIG) Investigators. (2014). Carboplatin plus paclitaxel once a
week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a
randomised, multicentre, open-label, phase 3 trial. Lancet Oncology 15,4:396-405.
Pujade-Lauraine, E., Hilpert, F., Weber, B., et al. (2014). Bevacizumab combined with
chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA openlabel randomized phase III trial. Journal of Clinical Oncology 32,13:1302-1308.
Stockler, M.R., Hilpert, F., Friedlander, M., et al. (2014). Patient-reported outcome
results from the open-label phase III AURELIA trial evaluating bevacizumabcontaining therapy for platinum-resistant ovarian cancer. Journal of Clinical Oncology
32,13:1309-1316.
Pathology, Staging, Polymorphisms & Biomarkers
Aristizabal, P., Graesslin, O., Barranger, E., et al. (2014). A suggested modification to
FIGO stage I endometrial cancer. Gynecologic oncology 133,2:192-196.
Bendifallah, S., Canlorbe, G., Raimond, E., et al. (2014). A clue towards improving the
European Society of Medical Oncology risk group classification in apparent early
stage endometrial cancer? Impact of lymphovascular space invasion. British journal
of cancer 110,11:2640-2646.
C Kitchener, H., Canfell, K., Gilham, C., et al. (2014). The clinical effectiveness and costeffectiveness of primary human papillomavirus cervical screening in England:
extended follow-up of the ARTISTIC randomised trial cohort through three
screening rounds. Health technology assessment (Winchester, England) 18,23:1-196.
3
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Chao, W.R., Lee, M.Y., Lin, W.L., et al. (2014). HER2 amplification and overexpression
are significantly correlated in mucinous epithelial ovarian cancer. Human pathology
45,4:810-816.
Giammarile, F., Bozkurt, M.F., Cibula, D., et al. (2014). The EANM clinical and technical
guidelines for lymphoscintigraphy and sentinel node localization in gynaecological
cancers. European Journal of Nuclear Medicine & Molecular Imaging 41,7:1463-1477.
Hockel, M., Hentschel, B. and Horn, L.C. (2014). Association between developmental
steps in the organogenesis of the uterine cervix and locoregional progression of
cervical cancer: a prospective clinicopathological analysis. Lancet Oncology 15,4:445456.
Meads, C., Sutton, A.J., Rosenthal, A.N., et al. (2014). Sentinel lymph node biopsy in
vulval cancer: systematic review and meta-analysis. British journal of cancer
110,12:2837-2846.
Raimond, E., Ballester, M., Hudry, D., et al. (2014). Impact of sentinel lymph node
biopsy on the therapeutic management of early-stage endometrial cancer: Results
of a retrospective multicenter study. Gynecologic oncology 133,3:506-511.
Waldron, L., Haibe-Kains, B., Culhane, A.C., et al. (2014). Comparative Meta-analysis of
Prognostic Gene Signatures for Late-Stage Ovarian Cancer. Journal of the National
Cancer Institute 106,5:
Wang, J., Gao, J., Yao, H., et al. (2014). Diagnostic accuracy of serum HE4, CA125 and
ROMA in patients with ovarian cancer: a meta-analysis. Tumour Biology 35,6:61276138.
Prognosis, Survival & Risk Factors
Kim, H.S., Kim, T.H., Chung, H.H., et al. (2014). Risk and prognosis of ovarian cancer in
women with endometriosis: a meta-analysis. British journal of cancer 110,7:1878-1890.
Shim, S.H., Lee, S.J. and Kim, S.N. (2014). Effects of hormone replacement therapy on
the rate of recurrence in endometrial cancer survivors: A meta-analysis. European
journal of cancer 50,9:1628-1637.
Zhang, X., Zhang, L., Tian, C., et al. (2014). Genetic variants and risk of cervical
cancer: epidemiological evidence, meta-analysis and research review. BJOG: An
International Journal of Obstetrics & Gynaecology 121,6:664-674.
Radiotherapy & Imaging
Andreano, A., Rechichi, G., Rebora, P., et al. (2014). MR diffusion imaging for
preoperative staging of myometrial invasion in patients with endometrial cancer: a
systematic review and meta-analysis. European radiology 24,6:1327-1338.
Barillot, I., Tavernier, E., Peignaux, K., et al. (2014). Impact of post operative intensity
modulated radiotherapy on acute gastro-intestinal toxicity for patients with
endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre
trial. Radiotherapy & Oncology 111,1:138-143.
4
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Jadon, R., Pembroke, C.A., Hanna, C.L., et al. (2014). A systematic review of organ
motion and image-guided strategies in external beam radiotherapy for cervical
cancer. Clinical Oncology (Royal College of Radiologists) 26,4:185-196.
Kirchheiner, K., Nout, R.A., Tanderup, K., et al. (2014). Manifestation pattern of earlylate vaginal morbidity after definitive radiation (chemo)therapy and image-guided
adaptive brachytherapy for locally advanced cervical cancer: an analysis from the
EMBRACE study. International journal of radiation oncology, biology, physics 89,1:88-95.
Klopp, A., Smith, B.D., Alektiar, K., et al. (2014). The role of postoperative radiation
therapy for endometrial cancer: Executive summary of an American Society for
Radiation Oncology evidence-based guideline. Practical Radiation Oncology 4,3:137144.
Ly, D., Rowley, B.D., Dodson, M.K., et al. (2014). Adjuvant radiation in early stage,
unfavorable histology endometrial carcinoma is associated with improved local
control and survival. Gynecologic oncology 133,2:250-255.
MacKintosh, M.L., Rahim, R., Rajashanker, B., et al. (2014). CT scan does not predict
optimal debulking in stage III-IV epithelial ovarian cancer: A multicentre validation
study. Journal of Obstetrics & Gynaecology 34,5:424-428.
Martinez-Monge, R., Cambeiro, M., Rodriguez-Ruiz, M.E., et al. (2014). Phase II trial of
image-based high-dose-rate interstitial brachytherapy for previously irradiated
gynecologic cancer. Brachytherapy 13,3:219-224.
Oh, S., Jaffray, D. and Cho, Y.B. (2014). A novel method to quantify and compare
anatomical shape: application in cervix cancer radiotherapy. Physics in Medicine &
Biology 59,11:2687-2704.
Supportive Care & Symptom Management
Angioli, R., Plotti, F., Capriglione, S., et al. (2014). The effects of giving patients verbal
or written pre-operative information in gynecologic oncology surgery: a
randomized study and the medical-legal point of view. European Journal of Obstetrics,
Gynecology, & Reproductive Biology 177,67-71.
Choi, C.H., Kim, M.K., Park, J.Y., et al. (2014). Safety and efficacy of aprepitant,
ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in
patients with ovarian cancer treated with paclitaxel/carboplatin. Supportive Care in
Cancer 22,5:1181-1187.
Del Mastro, L., Ceppi, M., Poggio, F., et al. (2014). Gonadotropin-releasing hormone
analogues for the prevention of chemotherapy-induced premature ovarian failure in
cancer women: systematic review and meta-analysis of randomized trials. Cancer
treatment reviews 40,5:675-683.
Friedlander, M.L., Stockler, M., O'Connell, R., et al. (2014). Symptom burden and
outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a
reality check: results of stage 1 of the gynecologic cancer intergroup symptom
benefit study. International Journal of Gynecological Cancer 24,5:857-864.
King, M.T., Stockler, M.R., Butow, P., et al. (2014). Development of the measure of
ovarian symptoms and treatment concerns: aiming for optimal measurement of
patient-reported symptom benefit with chemotherapy for symptomatic ovarian
cancer. International Journal of Gynecological Cancer 24,5:865-873.
Lefkowits, C., Binstock, A.B., Courtney-Brooks, M., et al. (2014). Predictors of palliative
5
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
care consultation on an inpatient gynecologic oncology service: are we following
ASCO recommendations?. Gynecologic oncology 133,2:319-325.
Oh, J.K., Park, N.H. and Oh, S.J. (2014). Effect of the systematised critical pathway
protocol on emptying failure as a secondary complication of radical hysterectomy
due to uterine cervix cancer. Journal of Clinical Nursing 23,11-12:1702-1707.
Rai, B., Dhanireddy, B., Patel, F.D., et al. (2014). Vaginal dose, toxicity and sexual
outcomes in patients of cervical cancer undergoing image based brachytherapy.
Asian Pacific Journal of Cancer Prevention: Apjcp 15,8:3619-3623.
Smolle, E., Taucher, V. and Haybaeck, J. (2014). Malignant ascites in ovarian cancer
and the role of targeted therapeutics. Anticancer Research 34,4:1553-1561.
Surgery
Ferrero, A., Ditto, A., Giorda, G., et al. (2014). Secondary cytoreductive surgery for
isolated lymph node recurrence of epithelial ovarian cancer: A multicenter study.
European Journal of Surgical Oncology 40,7:891-898.
Gala, R.B., Margulies, R., Steinberg, A., et al. (2014). Systematic review of robotic
surgery in gynecology: robotic techniques compared with laparoscopy and
laparotomy. Journal of Minimally Invasive Gynecology 21,3:353-361.
Kokka, F., Bryant, A., Brockbank, E., et al. (2014). Surgical treatment of stage IA2
cervical cancer. Cochrane Database of Systematic Reviews 5,010870.
Lundin, E.S., Johansson, T., Zachrisson, H., et al. (2014). Single-dose tranexamic acid in
advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind
placebo-controlled randomized multicenter study. Acta Obstetricia et Gynecologica
Scandinavica 93,4:335-344.
Rivard, C., Dickson, E.L., Vogel, R.I., et al. (2014). The effect of anesthesia choice on
post-operative outcomes in women undergoing exploratory laparotomy for a
suspected gynecologic malignancy. Gynecologic oncology 133,2:278-282.
Ryu, S.Y., Kim, M.H., Nam, B.H., et al. (2014). Intermediate-risk grouping of cervical
cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology
Group study. British journal of cancer 110,2:278-285.
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC library with
any queries.
If you have any questions regarding this or any other library services please contact Library staff –
contact details are at the beginning of the bulletin.
Sources used for this bulletin: OVID databases
6
Gynaecologic Oncology, July 2014
Kirsty Coltart, Subject Librarian, NHSGGC Library Network